Literature DB >> 9932451

Transcriptional and posttranscriptional regulation of proteoglycan gene expression.

R V Iozzo1, K G Danielson.   

Abstract

Proteoglycans are among the most complex and sophisticated molecules of mammalian systems in terms of their protein and carbohydrate moieties. These macromolecules are in a continuous interplay with each other and the cell surface signal-transducing pathways, some of which are beginning to be elucidated. Because of their domain structure, catalytic potential, and diversity, these molecules appear to be designed for integrating numerous signaling events. For example, some proteoglycans interact with hyaluronan and lectins, thereby linking cell surfaces and distant matrix molecules. Some interact with collagen during the complex process of fibrillogenesis and regulate this biological process fundamental to animal life. Others interact with growth factors and serve as depot available during growth or tissue remodeling. In this review, we center on the most recent developments of proteoglycan biology, focusing primarily on genomic organization and transcriptional and posttranscriptional control. We discuss only those proteoglycans whose gene and promoter elements have been characterized and proved to be functional. When possible, we correlate the effects of growth factors and cytokines on proteoglycan gene expression with the topology of cis-acting elements in their genomic control regions. The analysis leads to a comprehensive critical appraisal of the principles that underlie the regulation of proteoglycan gene expression and to the delineation of common regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9932451     DOI: 10.1016/s0079-6603(08)60504-8

Source DB:  PubMed          Journal:  Prog Nucleic Acid Res Mol Biol        ISSN: 0079-6603


  9 in total

Review 1.  The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy.

Authors:  Stephen Douglass; Atul Goyal; Renato V Iozzo
Journal:  Connect Tissue Res       Date:  2015-07-16       Impact factor: 3.417

Review 2.  Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans.

Authors:  Renato V Iozzo; Liliana Schaefer
Journal:  FEBS J       Date:  2010-08-31       Impact factor: 5.542

3.  Soluble lumican glycoprotein purified from human amniotic membrane promotes corneal epithelial wound healing.

Authors:  Lung-Kun Yeh; Wei-Li Chen; Wei Li; Edgar M Espana; Jie Ouyang; Tetsuya Kawakita; Winston W-Y Kao; Scheffer C G Tseng; Chia-Yang Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-02       Impact factor: 4.799

4.  Knockdown of zebrafish lumican gene (zlum) causes scleral thinning and increased size of scleral coats.

Authors:  Lung-Kun Yeh; Chia-Yang Liu; Winston W-Y Kao; Chang-Jen Huang; Fung-Rong Hu; Chung-Liang Chien; I-Jong Wang
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

Review 5.  Proteoglycans in brain development.

Authors:  Nancy B Schwartz; Miriam Domowicz
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

6.  First identification and functional analysis of the human xylosyltransferase II promoter.

Authors:  Benjamin Müller; Christian Prante; Cornelius Knabbe; Knut Kleesiek; Christian Götting
Journal:  Glycoconj J       Date:  2012-08-11       Impact factor: 2.916

7.  Decorin deficiency promotes epithelial-mesenchymal transition and colon cancer metastasis.

Authors:  Liping Mao; Jinxue Yang; Jiaxin Yue; Yang Chen; Hongrui Zhou; Dongdong Fan; Qiuhua Zhang; Simone Buraschi; Renato V Iozzo; Xiuli Bi
Journal:  Matrix Biol       Date:  2020-10-13       Impact factor: 11.583

Review 8.  Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.

Authors:  Renato V Iozzo; Ralph D Sanderson
Journal:  J Cell Mol Med       Date:  2011-05       Impact factor: 5.310

Review 9.  Proteoglycan form and function: A comprehensive nomenclature of proteoglycans.

Authors:  Renato V Iozzo; Liliana Schaefer
Journal:  Matrix Biol       Date:  2015-02-18       Impact factor: 11.583

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.